GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Meta Biomed Co Ltd (XKRX:059210) » Definitions » 3-Year Revenue Growth Rate

Meta Biomed Co (XKRX:059210) 3-Year Revenue Growth Rate : 21.80% (As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Meta Biomed Co 3-Year Revenue Growth Rate?

Meta Biomed Co's Revenue per Share for the three months ended in Dec. 2023 was ₩840.17.

During the past 12 months, Meta Biomed Co's average Revenue per Share Growth Rate was 17.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 21.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 9.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was -0.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Meta Biomed Co was 21.80% per year. The lowest was -13.70% per year. And the median was 2.20% per year.


Competitive Comparison of Meta Biomed Co's 3-Year Revenue Growth Rate

For the Medical Instruments & Supplies subindustry, Meta Biomed Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Meta Biomed Co's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Meta Biomed Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Meta Biomed Co's 3-Year Revenue Growth Rate falls into.



Meta Biomed Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Meta Biomed Co  (XKRX:059210) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Meta Biomed Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Meta Biomed Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Meta Biomed Co (XKRX:059210) Business Description

Traded in Other Exchanges
N/A
Address
634 Yeonje-ri, Gangoe-myeon, Cheongwon-gun, Chungbuk, KOR, 363-951
Meta Biomed Co Ltd manufactures and markets suture and dental supplies. The company's dental products include endodontic materials, restorative materials, and bone graft material, as well as equipment, including Endo motor, and Endo System. It also offers suture products comprising multifilament and monofilament products, as well as orthopedics and incontinence meshs; bone products consisting of bone substitutes and cement; and medical products, including endoscope and ultrasonic products.

Meta Biomed Co (XKRX:059210) Headlines

No Headlines